FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112110986> ?p ?o ?g. }

• W3112110986 endingPage "S53" @default.
• W3112110986 startingPage "S45" @default.
• W3112110986 abstract "Abstract Introduction Electronic cigarettes (ECIGs) expose users to an aerosol containing chemicals, which could affect the respiratory system negatively. This study examined negative respiratory symptoms associated with ECIG use. Methods In 2019, adult current ECIG users from 24 US states who reported experiencing negative respiratory symptoms from ECIG use (n = 49; 44.9% women; mean age = 35.2, SD = 11.5) completed an online survey and brainstormed statements that completed the prompt: “A specific negative effect or symptom related to my breathing, nose, mouth, throat, or lungs that I have experienced from vaping/using my e-cigarette is...” Participants sorted the final list of 56 statements into groups of similar content and rated statements on how true they were for them. Multidimensional scaling analysis identified thematic clusters. Results Eight ECIG use respiratory symptom clusters identified in analysis included Mucus and Congestion, Fatigue, Throat Symptoms, Breathing Problems, Mouth Symptoms, Chest Symptoms, Illness Symptoms, and Nose and Sinus Symptoms. Highly rated (ie, most common) symptoms included dry throat or mouth, fatigue during physical activity, coughing, shortness of breath, excessive phlegm, and bad taste in mouth. Mean cluster ratings did not differ based on lifetime cigarette smoking status (100 lifetime cigarettes smoked), but current cigarette smokers (ie, dual users) rated the Fatigue, Breathing Problems, Mucus and Congestion, and Nose and Sinus Symptoms clusters higher than noncurrent cigarette smokers. Conclusions Participant-identified respiratory symptoms perceived to be ECIG related, many similar to cigarette smoking symptoms. Future research should assess if these symptoms are associated with other negative health outcomes. Implications ECIG use exposes users to chemicals that may have negative health impacts on the respiratory system. Limited research has examined the broad range of negative respiratory symptoms associated with e-cigarette use. This study identified that ECIG–cigarette users perceive their ECIG use to be associated with negative respiratory symptoms. Many e-cigarette user-reported negative respiratory symptoms are similar to those associated with cigarette smoking, though some appear unique to e-cigarette use. Future research should continue to monitor respiratory symptoms reported by ECIG users and whether these are associated with health outcomes over time." @default.
• W3112110986 created "2020-12-21" @default.
• W3112110986 creator A5014590189 @default.
• W3112110986 creator A5055306186 @default.
• W3112110986 creator A5068612744 @default.
• W3112110986 creator A5069944493 @default.
• W3112110986 creator A5082946724 @default.
• W3112110986 creator A5000102661 @default.
• W3112110986 date "2020-12-01" @default.
• W3112110986 modified "2023-10-10" @default.
• W3112110986 title "User-Perceived Negative Respiratory Symptoms Associated with Electronic Cigarette Use" @default.
• W3112110986 cites W1969997111 @default.
• W3112110986 cites W1984519402 @default.
• W3112110986 cites W2016381774 @default.
• W3112110986 cites W2023795972 @default.
• W3112110986 cites W2053155195 @default.
• W3112110986 cites W2068439358 @default.
• W3112110986 cites W2100322844 @default.
• W3112110986 cites W2105131136 @default.
• W3112110986 cites W2128456085 @default.
• W3112110986 cites W2130764762 @default.
• W3112110986 cites W2131464370 @default.
• W3112110986 cites W2235288409 @default.
• W3112110986 cites W2280820730 @default.
• W3112110986 cites W2317962878 @default.
• W3112110986 cites W2473881746 @default.
• W3112110986 cites W2510550253 @default.
• W3112110986 cites W2514426073 @default.
• W3112110986 cites W2516346085 @default.
• W3112110986 cites W2532772377 @default.
• W3112110986 cites W2548700507 @default.
• W3112110986 cites W2613259465 @default.
• W3112110986 cites W2752221041 @default.
• W3112110986 cites W2760501691 @default.
• W3112110986 cites W2760578411 @default.
• W3112110986 cites W2767505013 @default.
• W3112110986 cites W2769573635 @default.
• W3112110986 cites W2770223145 @default.
• W3112110986 cites W2804642476 @default.
• W3112110986 cites W2811186368 @default.
• W3112110986 cites W2882999281 @default.
• W3112110986 cites W2884417236 @default.
• W3112110986 cites W2896294746 @default.
• W3112110986 cites W2914546128 @default.
• W3112110986 cites W2917649643 @default.
• W3112110986 cites W2918719455 @default.
• W3112110986 cites W2972010736 @default.
• W3112110986 cites W2990731843 @default.
• W3112110986 cites W4246354968 @default.
• W3112110986 cites W4248319617 @default.
• W3112110986 doi "https://doi.org/10.1093/ntr/ntaa179" @default.
• W3112110986 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7737476" @default.
• W3112110986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33320252" @default.
• W3112110986 hasPublicationYear "2020" @default.
• W3112110986 type Work @default.
• W3112110986 sameAs 3112110986 @default.
• W3112110986 citedByCount "9" @default.
• W3112110986 countsByYear W31121109862021 @default.
• W3112110986 countsByYear W31121109862022 @default.
• W3112110986 countsByYear W31121109862023 @default.
• W3112110986 crossrefType "journal-article" @default.
• W3112110986 hasAuthorship W3112110986A5000102661 @default.
• W3112110986 hasAuthorship W3112110986A5014590189 @default.
• W3112110986 hasAuthorship W3112110986A5055306186 @default.
• W3112110986 hasAuthorship W3112110986A5068612744 @default.
• W3112110986 hasAuthorship W3112110986A5069944493 @default.
• W3112110986 hasAuthorship W3112110986A5082946724 @default.
• W3112110986 hasBestOaLocation W31121109861 @default.
• W3112110986 hasConcept C126322002 @default.
• W3112110986 hasConcept C141071460 @default.
• W3112110986 hasConcept C142724271 @default.
• W3112110986 hasConcept C188947578 @default.
• W3112110986 hasConcept C204787440 @default.
• W3112110986 hasConcept C2776970978 @default.
• W3112110986 hasConcept C2776989088 @default.
• W3112110986 hasConcept C2777844070 @default.
• W3112110986 hasConcept C2778311950 @default.
• W3112110986 hasConcept C2778731716 @default.
• W3112110986 hasConcept C534529494 @default.
• W3112110986 hasConcept C71924100 @default.
• W3112110986 hasConceptScore W3112110986C126322002 @default.
• W3112110986 hasConceptScore W3112110986C141071460 @default.
• W3112110986 hasConceptScore W3112110986C142724271 @default.
• W3112110986 hasConceptScore W3112110986C188947578 @default.
• W3112110986 hasConceptScore W3112110986C204787440 @default.
• W3112110986 hasConceptScore W3112110986C2776970978 @default.
• W3112110986 hasConceptScore W3112110986C2776989088 @default.
• W3112110986 hasConceptScore W3112110986C2777844070 @default.
• W3112110986 hasConceptScore W3112110986C2778311950 @default.
• W3112110986 hasConceptScore W3112110986C2778731716 @default.
• W3112110986 hasConceptScore W3112110986C534529494 @default.
• W3112110986 hasConceptScore W3112110986C71924100 @default.
• W3112110986 hasFunder F4320332161 @default.
• W3112110986 hasFunder F4320332163 @default.
• W3112110986 hasFunder F4320337347 @default.
• W3112110986 hasFunder F4320337661 @default.
• W3112110986 hasIssue "Supplement_1" @default.
• W3112110986 hasLocation W31121109861 @default.

• next